LSL Pharma Group Signs Binding Agreement to Acquire Target
LSL Pharma Group has entered into a binding Letter of Intent (LOI) to acquire profitable privately held, Quebec-based competing contract drug manufacturer (CDMO), Target Co.
Contract Drug Manufacturer | 07/05/2024 | By Aishwarya | 660
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy